| __timestamp | Bausch Health Companies Inc. | Celldex Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 20622000 |
| Thursday, January 1, 2015 | 2682700000 | 33837000 |
| Friday, January 1, 2016 | 2810000000 | 35979000 |
| Sunday, January 1, 2017 | 2582000000 | 25003000 |
| Monday, January 1, 2018 | 2473000000 | 19269000 |
| Tuesday, January 1, 2019 | 2554000000 | 15426000 |
| Wednesday, January 1, 2020 | 2367000000 | 14456000 |
| Friday, January 1, 2021 | 2624000000 | 20488000 |
| Saturday, January 1, 2022 | 2625000000 | 27195000 |
| Sunday, January 1, 2023 | 2917000000 | 30914000 |
Igniting the spark of knowledge
In the ever-evolving landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. Bausch Health Companies Inc. and Celldex Therapeutics, Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses. Over the past decade, Bausch Health has consistently allocated a significant portion of its budget to SG&A, with a peak in 2023, marking a 44% increase from 2014. In contrast, Celldex Therapeutics, while maintaining a more modest SG&A budget, has shown a steady upward trend, with a 50% rise over the same period. This divergence highlights differing strategic priorities: Bausch's focus on expansive market reach versus Celldex's leaner, innovation-driven approach. As the industry faces new challenges, these spending patterns may offer insights into future growth trajectories.
Cost Management Insights: SG&A Expenses for Novo Nordisk A/S and Celldex Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Bausch Health Companies Inc.
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and Bausch Health Companies Inc.
Insmed Incorporated or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Ascendis Pharma A/S or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Comparing SG&A Expenses: ADMA Biologics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or Celldex Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Dynavax Technologies Corporation and Celldex Therapeutics, Inc.